-
Trastuzumab emtansine, sold
under the
brand name Kadcyla, is an antibody-drug
conjugate consisting of the
humanized monoclonal antibody trastuzumab (Herceptin)...
- Mertansine, also
called DM1 (and in some of its
forms emtansine), is a thiol-containing
maytansinoid that for
therapeutic purposes is
attached to a monoclonal...
-
conjugates for
cancer treatment, and the antibody-drug
conjugate trastuzumab emtansine is an
approved drug for the
treatment of
certain kinds of
breast cancer...
-
antibody with ImmunoGen's
thioether linker is
called "
emtansine" in its INN name
trastuzumab emtansine,
marketed as
Kadcyla DM1
attached to an
antibody with...
- also a
component of some antibody-drug conjugates, such as
trastuzumab emtansine, and
trastuzumab deruxtecan. "Trastuzumab - Drugs.com". www.drugs.com...
- the
European Medicines Agency in
October 2012.
Trastuzumab emtansine (ado-trastuzumab
emtansine or T-DM1,
trade name: Kadcyla,
marketed by
Genentech and...
-
Trastuzumab Trastuzumab deruxtecan Trastuzumab duocarmazine Trastuzumab emtansine Kinase inhibitors:
Afatinib Lapatinib Mubritinib Neratinib Tucatinib ErbB3/HER3...
-
Trastuzumab Trastuzumab deruxtecan Trastuzumab duocarmazine Trastuzumab emtansine Kinase inhibitors:
Afatinib Lapatinib Mubritinib Neratinib Tucatinib ErbB3/HER3...
-
approved to
treat acute myeloid leukemia. Two
other drugs,
trastuzumab emtansine and
brentuximab vedotin, are both in late
clinical trials, and the latter...
- (Picato)
which is used to
treat skin
cancer Maytenus ovatus Trastuzumab emtansine (Kadcyla) is an
antibody conjugated to a
synthetic derivative of the cytotoxic...
